To provide you with the best possible service, this website uses cookies. By continuing to browse this site, you agree to our use of cookies. Please refer to our [Privacy Policy] for more information. Please note that if you choose to disable cookies, some features of the site may not function properly.
2026-07-01
Corporate Updates
Hualien Tzu Chi Hospital and Botanicure Sign Memorandum of Understanding
In response to the growing "dementia tsunami" driven by population aging and the rapid increase in dementia cases worldwide, Hualien Tzu Chi Hospital and Botanicure officially signed a Memorandum of Understanding (MOU) on June 30, 2026, at Hualien Tzu Chi Hospital to jointly advance research and development in dementia prevention and treatment.
2026-06-25
Botanicure Presents Early Dementia Clinical Findings of Botanical Drug Development at BIO International Convention
As Taiwan enters a super-aged society, dementia has become an increasingly important public health concern. Speaking on behalf of the research team at the BIO International Convention in the United States, Dr. Chaur-Jong Hu, Dean of College of Medine, Taipei Medical University, noted that current dementia treatment strategies are moving toward “the earlier, the better.” He highlighted the growing attention surrounding Botanicure’s clinical findings on a botanical drug candidate targeting individuals at the earliest stages of cognitive decline.
2026-03-29
Corporate Updates
Botanicure Forum Explores New Botanical Drug Solutions for Dementia
To address dementia challenge, Botanicure co-hosted the "New Botanical Drug Solutions in the Era of Dementia Forum" together with Global Views Monthly.
